Kratom, a tropical tree native to Southeast Asia, has a long history of use for pain relief, energy, and mood improvement. Its leaves contain over 40 alkaloids that interact with opioid, serotonin, and dopamine receptors in the brain, producing effects that range from stimulant-like at low doses (1 to 5 grams) to sedative and pain-relieving at higher doses (5 to 15 grams). While many users report meaningful benefits, kratom also carries real risks, and it is not approved by the FDA for any medical use.
How Kratom Works in the Body
The primary active compound in kratom is mitragynine, which makes up 40% to 60% of the total alkaloid content. A second compound, 7-hydroxymitragynine, is present in much smaller amounts but binds to opioid receptors roughly nine times more strongly than mitragynine. Both compounds preferentially activate the same type of opioid receptor targeted by morphine and other painkillers, which explains kratom’s pain-relieving and mood-altering effects.
What sets kratom apart from conventional opioids is that its alkaloids also interact with serotonin, dopamine, and norepinephrine receptors. This broader pharmacological profile likely accounts for the stimulant and antidepressant-like effects users describe, particularly at lower doses. It also helps explain why kratom’s effects feel dose-dependent: a small amount can make you more alert and talkative, while a larger amount produces relaxation and pain relief.
Pain Relief
Pain management is the most commonly cited reason people use kratom, and there is controlled research supporting this claim. In a randomized, double-blind, placebo-controlled study published in the Yale Journal of Biology and Medicine, participants who drank a kratom preparation more than doubled their pain tolerance one hour later, from an average of 11.2 seconds to 24.9 seconds in a cold-water pain test. The placebo group showed no change. The study also found that the point at which participants first noticed pain was significantly delayed after kratom compared to placebo, and that subjective ratings of pain unpleasantness dropped as well.
The analgesic effect peaked at one hour and faded by two hours, suggesting that a single dose provides a relatively short window of relief. This aligns with what traditional users in Southeast Asia have long practiced: manual laborers, rubber tappers, farmers, and fishermen historically chewed fresh kratom leaves or brewed them into tea throughout the day to manage pain and fatigue from physically demanding work in extreme heat.
Energy and Productivity
At low to moderate doses (1 to 5 grams), kratom acts more like a stimulant than a sedative. Users commonly report feeling more energetic, alert, and motivated. In Southeast Asian communities where kratom use has a centuries-long tradition, men typically consume it in the morning specifically to improve work productivity and combat fatigue. Long-term users in surveys consistently describe feeling more capable of sustained physical labor and report increased sociability.
This stimulant effect likely comes from kratom’s interaction with norepinephrine and dopamine pathways rather than its opioid activity. Early pharmacological research dating back to the 1930s identified that mitragynine excites certain motor centers in the brain, which may contribute to the physical energy users feel. The key variable is dose: exceeding 5 grams tends to shift the experience toward sedation rather than stimulation.
Mood and Anxiety
Beyond pain and energy, many kratom users report improvements in mood, reduced anxiety, greater sociability, and increased empathy. These effects are consistent with kratom’s activity at serotonin and dopamine receptors. Research has shown that mitragynine binds to the same receptor subtypes targeted by certain antidepressant and antipsychotic medications, including specific serotonin receptors (5-HT2C and 5-HT7) and D2 dopamine receptors.
In traditional use across Southeast Asia, kratom leaves have been used as a household remedy for anxiety, and the plant is commonly consumed in social settings to promote relaxation and conversation. Some users also report heightened sexual desire, a finding supported by at least one Malaysian survey. While these mood effects are well-documented in observational and self-report studies, controlled clinical trials specifically measuring antidepressant or anxiolytic outcomes in humans are still limited.
Opioid Withdrawal Management
One of the more notable reported benefits is kratom’s ability to ease opioid withdrawal symptoms. Because kratom activates the same opioid receptors as heroin, oxycodone, and other opioids, it can reduce withdrawal symptoms like muscle aches, nausea, and agitation without producing the same intensity of effects. Case reports in the medical literature describe kratom substantially attenuating what would otherwise be severe opioid withdrawal.
Interestingly, when people stop using kratom itself, the withdrawal symptoms appear to be considerably milder than those associated with conventional opioids. Researchers have noted that mitragynine may also act on the same pathways as clonidine, a medication commonly prescribed to manage the autonomic symptoms of opioid withdrawal like sweating, racing heart, and anxiety. This dual mechanism could explain why kratom seems particularly effective for self-managed withdrawal, though medical supervision during opioid withdrawal is always safer than going it alone.
Liver Injury Risk
Kratom is not without serious health risks. Data from the U.S. Drug Induced Liver Injury Network identified 11 cases of liver damage attributed to kratom use. All patients developed jaundice, typically within about 14 days of starting kratom. The typical patient was a previously healthy male around age 40 who developed yellowing of the skin, itching, and significantly elevated liver enzymes. Eight of the 11 were hospitalized, though none died.
While 11 cases may seem small relative to the millions of estimated kratom users, liver injury from kratom tends to develop quickly and can be severe. The short latency period, just 5 to 28 days, means the risk is present even with relatively brief use. If you notice yellowing of your eyes or skin, dark urine, or persistent nausea after starting kratom, those are signs of possible liver damage that need immediate medical attention.
Drug Interaction Concerns
Kratom poses a meaningful risk of interacting with other medications. Its alkaloids strongly inhibit two liver enzymes, CYP2D6 and CYP3A, that are responsible for breaking down a wide range of common drugs. CYP2D6 metabolizes many antidepressants, beta-blockers, and certain pain medications. CYP3A processes roughly half of all prescription drugs on the market, including many statins, blood thinners, anti-seizure medications, and immunosuppressants.
When kratom blocks these enzymes, co-consumed medications can build up to higher-than-expected levels in your bloodstream, potentially causing toxicity. FDA modeling based on a modest 2-gram dose of kratom predicted clinically relevant interactions with both CYP3A and CYP2D6 substrates. If you take prescription medications of any kind, kratom’s enzyme-blocking effects are a serious consideration. Polyintoxication cases, where kratom was found alongside other drugs in people who experienced adverse events, have been a recurring theme in safety reports.
Regulatory Status and Overall Safety
The FDA has not approved kratom for any medical use. The agency classifies it as an adulterated dietary supplement and an unsafe food additive, warning consumers against using it for medical treatment. The FDA’s primary concerns are liver toxicity, seizure risk, and the potential for developing a substance use disorder. Kratom is legal at the federal level in the United States but banned or regulated in several states and municipalities.
The core tension with kratom is that the reported benefits are real for many users, particularly for pain and opioid withdrawal, but the lack of standardized products means potency varies wildly between batches and brands. Without quality control, you cannot reliably know how much mitragynine or 7-hydroxymitragynine you are consuming, which makes consistent dosing difficult and increases the risk of both underwhelming effects and adverse reactions. Contamination with heavy metals, salmonella, and other adulterants has also been documented in commercially sold kratom products.